- Corporate Officers - C
- Coughlin Timothy
Insider Trading History of Coughlin Timothy
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coughlin Timothy since 2015.
This trader's CIK number is 1376043.
At the time of last reporting, Coughlin Timothy was the Officer of Travere Therapeutics, Inc.. (stock ticker symbol TVTX).
Also see all insider trading activities at Travere Therapeutics, Inc..
Note that in the past
Coughlin Timothy also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fate Therapeutics Inc (FATE) by Coughlin Timothy
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | FATE | 0 | $0 | 1,439 | $32,823 | 0 | $0 |
| 2016 | FATE | 56,390 | $149,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Travere Therapeutics, Inc. (TVTX) by Coughlin Timothy
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | TVTX | 0 | $0 | 18,000 | $630,594 | 18,000 | $303,930 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Coughlin Timothy
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NBIX | 0 | $0 | 5,963 | $252,401 | 0 | $0 |
| 2016 | NBIX | 0 | $0 | 5,000 | $216,234 | 0 | $0 |
| 2015 | NBIX | 0 | $0 | 178,500 | $8,154,964 | 150,000 | $515,300 |
Yearly summary of insider trading at Atyr Pharma Inc (LIFE) by Coughlin Timothy
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | LIFE | 0 | $0 | 0 | $0 | 6,000 | $0 |
Insider trading activities at 4 companies by Coughlin Timothy:
1. Fate Therapeutics Inc (FATE)
2. Travere Therapeutics, Inc. (TVTX)
3. Neurocrine Biosciences Inc (NBIX)
4. Atyr Pharma Inc (LIFE)
Table 1. Insider trading of Fate Therapeutics Inc (FATE) by Coughlin Timothy
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-03 | FATE | Sale | 1,439 | 22.81 | 32,823 |
| 2016-11-23 | FATE | Buy | 56,390 | 2.66 | 149,997 |
Table 2. Insider trading of Travere Therapeutics, Inc. (TVTX) by Coughlin Timothy
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-10-31 | TVTX | Option Ex | 18,000 | 16.89 | 303,930 |
| 2025-10-31 | TVTX | Sale | 18,000 | 35.03 | 630,594 |
Table 3. Insider trading of Neurocrine Biosciences Inc (NBIX) by Coughlin Timothy
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-02-06 | NBIX | Sale | 963 | 43.14 | 41,543 |
| 2017-02-03 | NBIX | Sale | 1,500 | 42.55 | 63,824 |
| 2017-01-17 | NBIX | Sale | 1,750 | 40.65 | 71,137 |
| 2017-01-10 | NBIX | Sale | 1,750 | 43.37 | 75,897 |
| 2016-02-03 | NBIX | Sale | 1,500 | 38.06 | 57,090 |
| 2016-01-19 | NBIX | Sale | 1,750 | 46.69 | 81,707 |
| 2016-01-11 | NBIX | Sale | 1,750 | 44.25 | 77,437 |
| 2015-10-16 | NBIX | Sale | 25,000 | 47.78 | 1,194,500 |
| 2015-07-20 | NBIX | Option Ex | 20,000 | 5.76 | 115,200 |
| 2015-07-20 | NBIX | Sale | 20,000 | 55.00 | 1,100,000 |
| 2015-07-13 | NBIX | Option Ex | 20,000 | 5.76 | 115,200 |
| 2015-07-13 | NBIX | Sale | 20,000 | 50.00 | 1,000,000 |
| 2015-06-08 | NBIX | Option Ex | 60,000 | 2.59 | 155,400 |
| 2015-06-08 | NBIX | Sale | 60,000 | 45.08 | 2,704,800 |
| 2015-03-20 | NBIX | Sale | 40,000 | 44.49 | 1,779,600 |
| 2015-03-20 | NBIX | Option Ex | 40,000 | 2.59 | 103,600 |
| 2015-01-16 | NBIX | Sale | 1,750 | 30.81 | 53,917 |
| 2015-01-12 | NBIX | Sale | 1,750 | 28.37 | 49,647 |
| 2015-01-08 | NBIX | Option Ex | 10,000 | 2.59 | 25,900 |
| 2015-01-08 | NBIX | Sale | 10,000 | 27.25 | 272,500 |
Table 4. Insider trading of Atyr Pharma Inc (LIFE) by Coughlin Timothy
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-26 | LIFE | Option Ex | 6,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Coughlin Timothy
(Officer of Travere Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.